Position in ESPR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$0
+$0 QoQ
Shares Held
24,094
+14.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $26,283,345 across 23 Drug Manufacturers - Specialty & Generic names. ESPR ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
109,299 | $7,854,226 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
27,419 | $4,621,198 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,508 | $4,068,059 | |
| 4 | VTRS |
Viatris Inc
|
128,327 | $2,037,832 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
59,638 | $1,467,691 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
31,419 | $1,089,296 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
9,599 | $1,064,913 | |
| 8 | ALKS |
Alkermes plc.
|
16,250 | $851,500 |
All Filings in ESPR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 24,094 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | — | 20,974 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | — | 18,086 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | — | 15,588 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | — | 15,471 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | — | 13,941 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | — | 13,231 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | — | 12,086 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | — | 12,445 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||